CStone Pharmaceuticals (FRA:PH4) EV-to-Revenue : 1.43 (As of May. 10, 2024)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CStone Pharmaceuticals's enterprise value is €90.70 Mil. CStone Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €63.44 Mil. Therefore, CStone Pharmaceuticals's EV-to-Revenue for today is 1.43.

The historical rank and industry rank for CStone Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

FRA:PH4' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.69 Med: 6.18 Max: 25.92
Current: 1.43

During the past 8 years, the highest EV-to-Revenue of CStone Pharmaceuticals was 25.92. The lowest was 0.69. And the median was 6.18.

FRA:PH4's EV-to-Revenue is ranked better than
85.14% of 1036 companies
in the Biotechnology industry
Industry Median: 8.285 vs FRA:PH4: 1.43

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-10), CStone Pharmaceuticals's stock price is €0.136. CStone Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €0.05. Therefore, CStone Pharmaceuticals's PS Ratio for today is 2.62.

CStone Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for CStone Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals EV-to-Revenue Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

6.44

26.53

8.75

4.28

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial									26.53	-	8.75	-	4.28

Competitive Comparison of CStone Pharmaceuticals's EV-to-Revenue

For the Biotechnology subindustry, CStone Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CStone Pharmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CStone Pharmaceuticals's EV-to-Revenue falls into.

CStone Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CStone Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	90.703	/	63.435
	=	1.43

CStone Pharmaceuticals's current Enterprise Value is €90.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CStone Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €63.44 Mil.

CStone Pharmaceuticals (FRA:PH4) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CStone Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.136	/	0.052
	=	2.62

CStone Pharmaceuticals's share price for today is €0.136.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was €0.05.

CStone Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (FRA:PH4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (FRA:PH4) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

CSPHF:USA 02616:Hong Kong PH4:Germany

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (FRA:PH4) Headlines

No Headlines